Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock

Molecular Medicine

Volumn 14, Issue 5-6, 2008, Pages 257-263

  Nakada, Taka Aki ^a   Oda, Shigeto ^a   Matsuda, Ken Ichi ^b   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Abe, Ryuzo ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMANASHI PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; LACTIC ACID; POLY(METHYL METHACRYLATE);

ADSORPTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; FEMALE; FILTER; HEMODYNAMICS; HUMAN; INTENSIVE CARE; LACTATE BLOOD LEVEL; MALE; MEMBRANE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SEPTIC SHOCK;

AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; HEART RATE; HEMODIAFILTRATION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 44649144501     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00108.Nakada     Document Type: Article

References (29)

1. Cohen J. (2002) The immunopathogenesis of sepsis. Nature. 420:885-91.
2. Annane D, Bellissant E, Cavaillon JM. (2005) Septic shock. Lancet. 365:63-78.
3. Tracey KJ.(2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest. 117:289-96.
4. Kox WJ, Volk T, Kox SN, Volk HD. (2000) Immunomodulatory therapies in sepsis. Intensive Care Med. 26 Suppl 1:S124-8.
5. Bellomo R, Ronco C. (2001) Blood purification in the intensive care unit: evolving concepts. World J. Surg. 25:677-83.
6. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. (2002) Continuous hemofiltration/ hemodiafiltration in critical care. Ther. Apher. 6:193-8.
7. Kellum JA, Bellomo R, Mehta R, Ronco C. (2003) Blood purification in non-renal critical illness. Blood Purif. 21:6-13.
8. Ronco C, Bonello M, Bordoni V, Ricci Z, D'Intini V, Bellomo R, Levin NW. (2004) Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif. 22:164-74.
9. Honore PM et al. (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit. Care Med. 28:3581-7.
10. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. (2001) Current topics on cytokine removal technologies. Ther. Apher. 5:306-14.
11. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. (2001) High-volume haemofiltration in human septic shock. Intensive Care Med. 27:978-86.
12. Cornejo R et al. (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med. 32:713-22.
13. Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K. (2006) Blood purification for hypercytokinemia. Transfus. Apher. Sci. 35:253-64.
14. Hirasawa H, Oda S, Matsuda K. (2007) Continuous hemodiafiltration with cytokine-adsorbing hemofilter in the treatment of severe sepsis and septic shock. Contrib. Nephrol. 156:365-70.
15. Hirasawa H, Sugai T, Ohtake Y, Oda S, Matsuda K, Kitamura N. (1996) Blood purification for prevention and treatment of multiple organ failure. World J. Surg. 20:482-6.
16. Oda S, Hirasawa H, Shiga H, Matsuda K, Nakamura M, Watanabe E, Moriguchi T. (2005) Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther. Apher. Dial. 9:355-61.
17. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamua M. (2005) Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 29:169-75.
18. Bone RC et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 101:1644-55.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. (1985) APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-29.
20. Vincent JL et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit. Care Med. 26:1793-800.
21. Le Gall JR, Lemeshow S, Saulnier F. (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J.A.M.A. 270:2957-63.
22. Oda S, Hirasawa H, Sugai T, Shiga H, Matsuda K, Ueno H. (1998) Cellular injury score for multiple organ failure severity scoring system. J. Trauma. 45:304-10.
23. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. (2003) Current epidemiology of septic shock: the CUB-Rea Network. Am. J. Respir. Crit. Care Med. 168:165-72.
24. Dellinger RP et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 32:858-73.
25. Rivers E et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345:1368-77.
26. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. (1997) Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit. Care Med. 25:1813-9.
27. Nylen ES, Alarifi AA. (2001) Humoral markers of severity and prognosis of critical illness. Best Pract. Res. Clin. Endocrinol. Metab. 15:553-73.
28. Honore PM, Joannes-Boyau O, Gressens B. (2007) Blood and plasma treatments: high-volume hemofiltration - a global view. Contrib. Nephrol. 156:371-86.
29. Hirasawa H, Oda S, Shiga H, Matsuda K. (2000) Endotoxin adsorption or hemodiafiltration in the treatment of multiple organ failure. Curr. Opin. Crit. Care 6:421-5.